Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00171249
Status:
COMPLETED
Last Update Posted:
2021-07-22
First Post:
2005-09-12
Brief Title:
An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph Leukemia
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
1999-08-09
Start Date Type:
ACTUAL
Primary Completion Date:
2013-09-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-09-23
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-12
First Submit QC Date:
September 12 2005
Study First Post Date:
2005-09-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-07-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-01
Last Update Post Date:
2021-07-22
Last Update Post Date Type:
ACTUAL